Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

News Daily News

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

Caitlin E. Cox

December 27, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Daily News

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

Michael O'Riordan

March 04, 2024

News Conference News EACTS 2023

Surgeons Support Proposed Changes to Left Main CAD Guidelines

Michael O'Riordan

October 13, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Conference News EAS 2023

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

Michael O'Riordan

May 25, 2023

News Daily News

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Michael O'Riordan

February 24, 2023

News Daily News

DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain

Michael O'Riordan

March 04, 2022

News Conference News TCT 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

Michael O'Riordan

October 21, 2021

News Conference News EACTS 2021

Left Main Guideline Review Looms as EACTS Surgeons Urge CABG First

Michael O'Riordan

October 19, 2021

News Daily News

Coronary Revascularization Benefits Even Latecomer STEMI: FAST-MI Registry

Michael O'Riordan

September 21, 2021

News Conference News ESC 2021

TOMAHAWK: Swift Angiography No Benefit in OHCA Without STEMI

Shelley Wood

August 29, 2021

News Conference News ISC 2021

Speeding Stroke Care With Mobile Units, Direct Angio Pays Dividends

Todd Neale

March 17, 2021

News Conference News PCR London Valves 2020

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

Shelley Wood

November 26, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Daily News

CT Perfusion Imaging for In-Stent Restenosis Shows Promise

Yael L. Maxwell

August 15, 2019

Presentation TCT Abstracts Posters 2018

Therapeutic pathways for new onset stable chest pain patients in Germany - Mapping of treatment landscape in a German statutory health insurance claims data analysis

Presenter: Roisin Colleran

September 25, 2018

News Conference News ESC 2018

VERDICT: Very Early Invasive Angiography No Help Overall for NSTE ACS

Todd Neale

August 29, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

Advertisement

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

DES Best for In-Stent Restenosis, but DCBs Also Viable

April 2024 Dispatch for the CV Team

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

Surgeons Support Proposed Changes to Left Main CAD Guidelines

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain

Good Long-term Results With FANTOM BVS, but More Data Needed

Left Main Guideline Review Looms as EACTS Surgeons Urge CABG First

Coronary Revascularization Benefits Even Latecomer STEMI: FAST-MI Registry

TOMAHAWK: Swift Angiography No Benefit in OHCA Without STEMI

Speeding Stroke Care With Mobile Units, Direct Angio Pays Dividends

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

CT Perfusion Imaging for In-Stent Restenosis Shows Promise

Therapeutic pathways for new onset stable chest pain patients in Germany - Mapping of treatment landscape in a German statutory health insurance claims data analysis

VERDICT: Very Early Invasive Angiography No Help Overall for NSTE ACS

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content